• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基层医疗中糖尿病的患病率及药物治疗]

[Prevalence and pharmacotherapy of diabetes mellitus in primary care].

作者信息

Lehnert H, Wittchen H-U, Pittrow D, Bramlage P, Kirch W, Böhler S, Höfler M, Ritz E

机构信息

Klinik für Endokrinologie und Stoffwechselkrankheiten, Universität Magdeburg.

出版信息

Dtsch Med Wochenschr. 2005 Feb 18;130(7):323-8. doi: 10.1055/s-2005-863050.

DOI:10.1055/s-2005-863050
PMID:15712019
Abstract

BACKGROUND AND OBJECTIVE

So far only incomplete epidemiological data on the management of diabetes mellitus have been available for the Federal Republic of Germany. It was the aim of this study to obtain such information from a representative cross-section of patients.

PATIENTS AND METHODS

43549 consecutive, unselected patients (52.6% females; mean age 64.9 +/- 11.7 years) of general practitioners and internists in private practice were included in this study which was based on data provided by the general practitioners or internists during September 2001. They recorded prevalence of diabetes, hypertension and 22 other diseases, and the patients' current treatment. Also recorded were associations of other patient-related variables (age, gender, associated or resulting diseases, hypertension, micro- and macrovascular complications, obesity), with medical practitioner-related variables (medical training, use of guidelines, regional factors) and with the frequency of antidiabetic treatment (total and differentiated by class of drug).

RESULTS

The prevalence of diabetes mellitus in this cohort was 15.6% (18.5% for males and 13.7% for females). 67.6% of the diabetics received antidiabetic medication. There was little difference, between the different age groups and between males and females, with regard to which of the various drugs were prescribed. Patients with macrovascular complications were more intensively treated with antidiabetics than those with exclusively microvascular ones. There was hardly any correlation between patterns of prescription and various practitioner characteristics (medical training, use of guidelines, regional factors).

CONCLUSION

There was little differentiation in the prescription of antidiabetic medication by general practitioners/internists among an unselected patient cohort.

摘要

背景与目的

迄今为止,关于德意志联邦共和国糖尿病管理的流行病学数据尚不完整。本研究旨在从具有代表性的患者样本中获取此类信息。

患者与方法

本研究纳入了43549例连续的、未经筛选的私人执业全科医生和内科医生的患者(女性占52.6%;平均年龄64.9±11.7岁),研究基于2001年9月全科医生或内科医生提供的数据。他们记录了糖尿病、高血压和其他22种疾病的患病率以及患者当前的治疗情况。还记录了其他与患者相关的变量(年龄、性别、相关或并发疾病、高血压、微血管和大血管并发症、肥胖)与医生相关变量(医学培训、指南使用、地区因素)以及与抗糖尿病治疗频率(总体及按药物类别区分)之间的关联。

结果

该队列中糖尿病的患病率为15.6%(男性为18.5%,女性为13.7%)。67.6%的糖尿病患者接受了抗糖尿病药物治疗。在不同年龄组以及男性和女性之间,所开的各种药物差异不大。患有大血管并发症的患者比仅患有微血管并发症的患者接受了更强化的抗糖尿病治疗。处方模式与各种医生特征(医学培训、指南使用、地区因素)之间几乎没有相关性。

结论

在未经筛选的患者队列中,全科医生/内科医生在抗糖尿病药物处方方面几乎没有差异。

相似文献

1
[Prevalence and pharmacotherapy of diabetes mellitus in primary care].[基层医疗中糖尿病的患病率及药物治疗]
Dtsch Med Wochenschr. 2005 Feb 18;130(7):323-8. doi: 10.1055/s-2005-863050.
2
[Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].[全科医生报告的糖尿病患病率、抗糖尿病治疗及慢性糖尿病并发症情况]
Przegl Lek. 2005;62(4):201-5.
3
[How many and who are receiving medication for diabetes mellitus?].[有多少人以及哪些人正在接受糖尿病药物治疗?]
Tidsskr Nor Laegeforen. 2006 Mar 9;126(6):768-70.
4
[Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].[2型糖尿病患者的降糖药物及耗材成本与治疗满意度。医疗保健研究LIVE-DE(德国甘精胰岛素与中性鱼精蛋白锌胰岛素对比)研究结果]
Dtsch Med Wochenschr. 2009 Jun;134(23):1207-13. doi: 10.1055/s-0029-1222595. Epub 2009 May 26.
5
Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.儿童和青少年中抗高血压、抗糖尿病和降血脂处方药的使用 prevalence
Arch Pediatr Adolesc Med. 2009 Apr;163(4):357-64. doi: 10.1001/archpediatrics.2009.5.
6
Evaluation of urolithiasis: a link between stone formation and diabetes mellitus?尿路结石的评估:结石形成与糖尿病之间存在关联?
Urol Int. 2009;82(3):350-5. doi: 10.1159/000209371. Epub 2009 May 11.
7
Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.2 型糖尿病和用于治疗 2 型糖尿病的药物与德国初级保健队列中癌症的发病风险和死亡率相关。
Metabolism. 2011 Oct;60(10):1363-71. doi: 10.1016/j.metabol.2010.09.012. Epub 2010 Nov 16.
8
Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.罗格列酮与吡格列酮单药治疗对参加医疗补助计划的2型糖尿病患者的起始治疗及相关医疗保健利用情况的比较
Clin Ther. 2007 Jun;29(6 Pt 1):1306-15. doi: 10.1016/j.clinthera.2007.06.019.
9
Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.2型糖尿病药物治疗的依从性:一项针对有雇主提供医疗保险的成年人的回顾性队列研究。
Clin Ther. 2005 Jul;27(7):1064-73. doi: 10.1016/j.clinthera.2005.07.009.
10
[Quality of diabetes care in Norwegian general practice].[挪威全科医疗中的糖尿病护理质量]
Tidsskr Nor Laegeforen. 2008 Nov 20;128(22):2570-4.

引用本文的文献

1
Prevalence, incidence and mortality of diabetes mellitus in adults in Germany - A review in the framework of the Diabetes Surveillance.德国成年人糖尿病的患病率、发病率和死亡率——糖尿病监测框架下的综述
J Health Monit. 2017 Oct 9;2(3):98-121. doi: 10.17886/RKI-GBE-2017-062. eCollection 2017 Oct.
2
Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study.一般人群心血管危险因素及其决定因素的控制——STAAB队列研究结果
BMC Cardiovasc Disord. 2017 Nov 2;17(1):276. doi: 10.1186/s12872-017-0708-x.
3
Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older.
适用于糖尿病患者的移动应用程序:一项系统评价及基于专家的可用性评估,该评估考虑了50岁及以上糖尿病患者的特殊需求。
J Med Internet Res. 2014 Apr 9;16(4):e104. doi: 10.2196/jmir.2968.
4
Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study.2 型糖尿病患者糖尿病和冠心病药物治疗中的性别差异:来自 DIANA 研究的结果。
Cardiovasc Diabetol. 2012 Jul 27;11:88. doi: 10.1186/1475-2840-11-88.
5
[Medical decision making in symptoms of type 2 diabetes mellitus in general practice].[基层医疗中2型糖尿病症状的医疗决策]
Dtsch Med Wochenschr. 2011 Feb;136(8):359-64. doi: 10.1055/s-0031-1272536. Epub 2011 Feb 17.
6
First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.糖尿病前期患者的一线降压治疗:ADaPT研究的理论依据、设计及基线结果
Cardiovasc Diabetol. 2008 Jul 24;7:22. doi: 10.1186/1475-2840-7-22.
7
Antihypertensive effect of irbesartan and predictors of response in obesity-associated hypertension : a prospective, open-label study.厄贝沙坦的降压作用及肥胖相关性高血压反应的预测因素:一项前瞻性、开放标签研究。
Clin Drug Investig. 2005;25(12):765-76. doi: 10.2165/00044011-200525120-00003.
8
The economic burden of diabetic retinopathy in Germany in 2002.2002年德国糖尿病视网膜病变的经济负担。
Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):151-9. doi: 10.1007/s00417-007-0573-x. Epub 2007 Apr 4.